Welcome to myAZmed

This is a non-promotional website developed and funded by AstraZeneca and it is intended for UK patients, or their carers, who have been prescribed an AstraZeneca medicine. This website is not intended to replace the discussions between you and your healthcare professional and it is not a substitute for the Patient Information Leaflet which is provided with your medicine.

 

Please select the option below which applies to you.

LEARN ABOUT AN ASTRAZENECA MEDICINE YOU HAVE BEEN PRESCRIBED

If you are a UK patient, or their carer, prescribed an AstraZeneca medicine, please enter myAZmed using the button below.

DISCOVER DISEASE EDUCATION AND SUPPORT FROM ASTRAZENECA

Discover disease education and resources for some of the conditions relevant to AstraZeneca’s work, using the button below.

If you are a UK healthcare professional looking for further information, you can visit our AZ UK Medical Information website.

 

If none of the above options apply, this website is not appropriate for you. To learn more about AstraZeneca as a company you 
can visit astrazeneca.co.uk.

I am a member of the UK public looking for disease education

This website is intended for UK patients, or their carers, who have been prescribed an AstraZeneca medicine. If this is not you, please go to https://www.astrazeneca.co.uk/

logo
  • About myAZmed

Ooops, page not found

Sorry but this page has either been removed, changed its name or is temporarily unavailable. 

GO BACK GO TO HOMEPAGE

Approval ID: GB-69418 Date of preparation: September 2025

Reporting side effects

 

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in the Patient Information Leaflet. You can also report side effects directly via the Yellow Card Scheme website: www.mhra.gov.uk/yellowcard. By reporting side effects, you can help provide more information on the safety of medicines.

  
FOOTER LOGO
  • Cookie policy
  • Terms of use
  • Privacy policy
  • Contact us

© Copyright 2022. AstraZeneca Ltd

Approval ID: GB-53223 Date of preparation: May 2024